...
首页> 外文期刊>Palliative medicine >Reconciling informed consent and 'do no harm': ethical challenges in palliative-care research and practice in chronic obstructive pulmonary disease.
【24h】

Reconciling informed consent and 'do no harm': ethical challenges in palliative-care research and practice in chronic obstructive pulmonary disease.

机译:调和知情同意和“无害”:慢性阻塞性肺疾病的姑息治疗研究和实践中的伦理挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

The challenges associated with patient-based research in palliative care are well documented. This paper focuses on the ethical challenges and discusses them in the context of a pilot study to explore the palliative-care needs of patients with moderate and severe chronic obstructive pulmonary disease. The main ethical challenge encountered related to problems surrounding the use of terminology, specifically the terms 'palliative care' and 'chronic obstructive pulmonary disease'. The approving ethics committee specified that these terms be removed from all patient materials in order to protect patients from undue distress. The impact of this ethical advice on patients' ability to give fully informed consent is discussed. This paper highlights a requirement for appropriately resourced and well-managed studies in palliative care, and identifies a need for the development of appropriate strategies in order to ensure the informed participation of patients with non-cancer diagnoses in palliative-care research.
机译:文献记载了与基于患者的姑息治疗研究相关的挑战。本文着重于道德挑战,并在试点研究中讨论了这些挑战,以探索中度和重度慢性阻塞性肺疾病患者的姑息治疗需求。遇到的主要道德挑战与术语使用有关的问题有关,特别是术语“姑息治疗”和“慢性阻塞性肺疾病”。批准伦理委员会规定,应从所有患者材料中删除这些术语,以保护患者免于过度痛苦。讨论了这种道德建议对患者给予充分知情同意的能力的影响。本文强调了对姑息治疗中资源充足且管理良好的研究的要求,并确定了开发适当策略的需求,以确保非癌症诊断患者知情参与姑息治疗研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号